施贵宝宣布,其针对青少年症状性梗阻性肥厚型心肌病(oHCM)的药物Camzyos(Mavacamten)所开展的三期SCOUT-HCM临床试验,获得了积极的顶线结果。
施贵宝宣布,其针对青少年症状性梗阻性肥厚型心肌病(oHCM)的药物Camzyos(Mavacamten)所开展的三期SCOUT-HCM临床试验,获得了积极的顶线结果。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.